Composition and method for dermal and transdermal administration

Details Composition and method for dermal and transdermal administration Composition and method for dermal and transdermal administration

1998-12-18

2000-12-26

Russel, Jeffrey E.

Drug, bio-affecting and body treating compositions

Lymphokine

424 852, 424 854, 424 855, 424 856, 424 857, 4242831, 530351, 530410, A61K 3819, A61K 3820, A61K 3821

Patent

active

061654582

ABSTRACT:
A composition for transdermal administration of a cytokine is described. The composition includes a conjugate composed of a cytokine, such as an interferon, and at least one fatty acid moiety covalently attached to the cytokine. The conjugate has enhanced cutaneous delivery relative to the cytokine alone.

REFERENCES:
patent: 4454065 (1984-06-01), Gilvarg et al.
patent: 4957733 (1990-09-01), Cole et al.
patent: 5030716 (1991-07-01), Fleischmann
patent: 5359030 (1994-10-01), Ekwuribe
patent: 5411947 (1995-05-01), Hostetler et al.
patent: 5629020 (1997-05-01), Leone-Bay et al.
patent: 5650386 (1997-07-01), Leone-Bay et al.
Bakouche et al. Acylation of Cell-Associated IL-1 by Palmitic Acid. J. Immunology. vol. 147, No. 7, pp. 2164-2169, Oct. 1, 1991.
Bursten et al. Acylation of Monocyte and Glomerular Mesangial . . . J. Clin. Invest. vol. 82, pp. 1479-1488, Nov. 1988.
Stevenson et al. Myrsityl Acylation of the Tumor Necrosis Factor . . . J. Exp. Med. vol. 176, pp. 1053-1062, Oct. 1992.
Stevenson et al. The 31 kDa precursor of Interleukin 1.alpha. . . . PNAS USA. vol. 90, pp. 7245-7249, Aug. 1993.
Utsumi et al. Preparation and Characterization of Liposomal-Lipophilc . . . Cancer Research, vol. 51, pp. 3362-3366, Jul. 1, 1991.
Foldvari et al. Palmitayl derivatives of interferon alpha . . . J. Pharm. Sci. vol. 87, No. 10, pp. 1203-1208, Oct. 1998.
Cierniewski, C.S. et al., "Palmitylation of Glycoprotein Iib-IIIa Complex in Human Blood Platelets," The Journal of Biological Chemistry. 264:(21) 12158-12164 (1989).
Conte, A. et al., "Recent Findings on the Regulatory Functions of CoA and the Normalizing Activity on Plasma Lipids of Exogenous CoA," Drugs Exptl. Clin. Res. 28: (5) 179-188 (1992).
Egbaria, K et al., "Topical Delivery of Liposomally Encapsulated Interferon Evaluated by In Vitro Diffusion Studies," Antimicrobial Agents and Chemotherapy. 34: (01) (1990), pp. 107-110.
Liu, J. et al., "New Approaches for the Preparation of Hydrophobic Heparin Derivatives," Journal of Pharmaceutical Sciences. 83:(07) 1034-1039 (1994).
Staufenbiel, M., "Fatty Acids Covalently Bound to Erythrocyte Proteins Undergo a Differential Turnover in Vivo," The Journal of Biological Chemistry. 263: (27) 13615-13622 (1988).
Travers, J.B. et al., "Platelet-Activating Factor Biosynthesis Induced by Various Stimuli in Human HaCaT Keratinocytes," The Journal of Investigative Dermatology. 107: (1996), pp. 88-94.
Weiner, N. et al., "Topical Delivery of Liposomally Encapsulated Interferon Evaluated in a Cutaneous Herpes Guinea Pig Model," Antimicrobial Agents and Chemotherapy. 33: (08) 1217-1221 (1989).
Wood, P.R. and Seow, H.F, "T Cell Cytokines and Disease Prevention," Veterinary Immunology and Immunopathology. 54:33-44 (1996).
Zhao, Z. and Leong, K.W., "Controlled Delivery of Antigens and Adjuvants in Vaccine Development," Journal of Pharmaceutical Sciences. 85: (12) 1261-1270 (1996).

Affiliated with

Also associated with

Rating

Composition and method for dermal and transdermal administration does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Composition and method for dermal and transdermal administration, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method for dermal and transdermal administration will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-991605